COVID-19 is identified as a zoonotic disease caused by SARS-CoV-2, which also can cross-
transmit to many animals but not mice. Genetic modifications of SARS-CoV-2 or mice enable …

Convalescent plasma (CP) has emerged as a treatment for COVID-19. However, the
composition and mechanism of action are not fully known. Therefore, we undertook a two …

Pharmaceuticals | Free Full-Text | Protective Effect of Vitamin D Supplementation on COVID-19-Related
Intensive Care Hospitalization and Mortality: Definitive Evidence from Meta-Analysis and …

Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection of
the respiratory system can progress to a multisystemic disease with aberrant inflammatory …

COVID-19 patients have a high incidence of thrombosis, and thromboembolic complications
are associated with severe COVID-19 and high mortality. COVID-19 disease is associated …

Myocarditis is the progressive inflammation of the middle layer of the heart followed by a
myocardial injury without ischemic events [1, 2]. The infectious and non-infectious causes of …

Introduction: During the COVID-19 pandemic thyroid gland alteration/dysfunction has been
emerged as a possible endocrine complication. The present review is focused on …

Background: Numerous cases of the coronavirus disease 2019 (COVID-19) with
autoimmune and rheumatic manifestations have been reported. Despite the available …

Chronic pain management during the coronavirus disease 2019 (COVID-19) pandemic is a
challenging process, especially with growing evidence that COVID-19 infection is …

Background: Intensive care patients commonly develop muscle wasting and functional
impairment. However, the role of severe COVID-19 in the magnitude of muscle wasting and …